Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ECC 2013 Preview: Expectations for ECC 2013

Prof Graeme Poston, Prof Vincenzo Valentini and Ian Banks
ECC 2013 Preview: Expectations for ECC 2013 ( Prof Graeme Poston, Prof Vincenzo Valentini and Ian Banks )
11 Jul 2013

ECC 2013 Preview: Scientific programme highlights

Prof Vincenzo Valentini and Ian Banks
ECC 2013 Preview: Scientific programme highlights ( Prof Vincenzo Valentini and Ian Banks )
11 Jul 2013

Age and ageing in blood disorders

Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands
Age and ageing in blood disorders ( Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands )
19 Jun 2013

Rituximab for b-cell lymphoma and EHA overview

Prof Ulrich Jäger - EHA President and Vienna Medical University, Austria
Rituximab for b-cell lymphoma and EHA overview ( Prof Ulrich Jäger - EHA President and Vienna Medical University, Austria )
19 Jun 2013

Highlights from EHA 2013

Prof Anton Hagenbeek - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands
Highlights from EHA 2013 ( Prof Anton Hagenbeek - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands )
19 Jun 2013

Strategies to maintain remission in high risk CD19 lymphoid malignancies

Dr Partow Kebriaei - MD Anderson Cancer Center, Houston, USA
Strategies to maintain remission in high risk CD19 lymphoid malignancies ( Dr Partow Kebriaei - MD Anderson Cancer Center, Houston, USA )
19 Jun 2013

Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma

Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands
Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma ( Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands )
17 Jun 2013

Importance of the immune system in cancer

Prof Leif Håkansson - Linköping University Hospital, Sweden
Importance of the immune system in cancer ( Prof Leif Håkansson - Linköping University Hospital, Sweden )
14 Jun 2013

Science behind phase I clinical trials: targeting tumour cell development pathways

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
Science behind phase I clinical trials: targeting tumour cell development pathways ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013

Comment on progression free survival in lung cancer patients and the GALAXY-1 trial

Dr Marjorie G. Zauderer - Memorial Sloan-Kettering Cancer Center, New York, USA
Comment on progression free survival in lung cancer patients and the GALAXY-1 trial ( Dr Marjorie G. Zauderer - Memorial Sloan-Kettering Cancer Center, New York, USA )
3 Jun 2013

Crizotinib and molecular testing in advanced non small cell lung cancer

Dr Fred Hirsch - University of Colorado, Denver, USA
Crizotinib and molecular testing in advanced non small cell lung cancer ( Dr Fred Hirsch - University of Colorado, Denver, USA )
3 Jun 2013

Nintedanib in combination with standard second line therapy in lung cancer

Dr Martin Reck - Hospital Grosshansdorf, Wohrendamm, Germany
Nintedanib in combination with standard second line therapy in lung cancer ( Dr Martin Reck - Hospital Grosshansdorf, Wohrendamm, Germany )
3 Jun 2013